Latest Breaking News On - Nd colob dk0060448595 - Page 1 : comparemela.com

EARNINGS/SALES RELEASESColoplast has reported a 8% rise in Q2 23 revenue, driven by double-digit growth in wound and skin care, and in interventional urology. However, gross margin erosion and higher. | May 11, 2023

Coloplastas stock exchangePress releaseNd colob dk0060448595